Dr. Kevin Rouse, MD
Claim this profileGSK Investigational Site
Studies Meningococcal Disease
Studies Pneumonia
7 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Kevin Rouse, MD is currently running
VAX-24 Pneumococcal Vaccine
for Infants
The objective of the study is to evaluate the safety and tolerability of 4 injections of VAX-24 (at 3 dose levels) compared to PCV15 in infants at 2, 4, 6, and 12-15 months of age, in addition to receiving routine US concomitant vaccines. Stage 1 of the study will comprise 3 dose ascending cohorts. Stage 2 of the study will enroll the remainder of the sample size.
Recruiting1 award Phase 27 criteria
AFX3772 Vaccine
for Pneumococcal Infections
This trial tests a new vaccine called AFX3772 in healthy infants to prevent pneumococcal disease. The vaccine aims to help their immune systems recognize and fight off the bacteria that cause this disease.
Recruiting1 award Phase 21 criteria
More about Kevin Rouse, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kevin Rouse, MD has experience with
- AFX3772
- Prevnar 13
- Bexsero (rMenB+OMV NZ)
- Prevnar13
- RMenB+OMV NZ Vaccine
- MenABCWY-3
Breakdown of trials Kevin Rouse, MD has run
Meningococcal Disease
Bacterial Pneumonia
Pneumococcal Infections
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Rouse, MD specialize in?
Kevin Rouse, MD focuses on Meningococcal Disease and Pneumonia. In particular, much of their work with Meningococcal Disease has involved treating patients, or patients who are undergoing treatment.
Is Kevin Rouse, MD currently recruiting for clinical trials?
Yes, Kevin Rouse, MD is currently recruiting for 2 clinical trials in Jonesboro Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Kevin Rouse, MD has studied deeply?
Yes, Kevin Rouse, MD has studied treatments such as AFX3772, Prevnar 13, Bexsero (rMenB+OMV NZ).
What is the best way to schedule an appointment with Kevin Rouse, MD?
Apply for one of the trials that Kevin Rouse, MD is conducting.
What is the office address of Kevin Rouse, MD?
The office of Kevin Rouse, MD is located at: GSK Investigational Site, Jonesboro, Arkansas 72401 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.